glp-1 atlanta Programs | Medical Weight Loss Injections | TrimRx GLP-1 Weight Loss Atlanta |
Description
The STEP 1 trial reported an average body-weight reduction of 14.9% with branded injectable semaglutide 2.4 mg over 68 weeks
The numbers tell the story
Emphasis on Indication [Dulaglutide (Trulicity), Exenatide (Bydureon, Byetta), Liraglutide (Victoza, Saxenda), Semaglutide (Ozempic, Wegovy, Rybelsus), Tirzepatide (Mounjaro, Zepbound)]
J Clin Endocrinol Metab 2020;105:dgz047.PubMed 49
After six months, women reduced their average body weight from 156 pounds (71 kg) to 137 pounds (62 kg), reflecting a 12% weight loss
